Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation

American Journal of Transplantation

Volumn 3, Issue 4, 2003, Pages 484-491

  Goldstein, Daniel R ^a   Coffey, Christopher S ^b   Benza, Raymond L ^c   Nanda, Navin C ^c   Bourge, Robert C ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Acute rejection; Bradycardia; Heart transplantation

Indexed keywords

AMIODARONE; AZATHIOPRINE; CYCLOSPORIN; DILTIAZEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THEOPHYLLINE;

ADULT; AGE; AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; GRAFT REJECTION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGEON;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BRADYCARDIA; CASE-CONTROL STUDIES; HEART TRANSPLANTATION; HUMANS; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0038666475     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00073.x     Document Type: Article

References (35)

1. Miyamoto Y, Curtiss EI, Kormos RL, Armitage JM, Hardesty RL, Griffith BP. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 1990; 82 (Suppl): 313-317.
2. Montero JA, Anguita M, Concha M et al. Pacing requirements after orthotopic heart transplantation: incidence and related factors. J Heart Lung Transplant 1992; 11: 799-802.
3. DiBiase A, Tse TM, Schnittger I, Wexler L, Stinson EB, Valantine HA. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991; 67: 1385-1389.
4. Heinz G, Kratochwill C, Schmid S et al. Sinus node dysfunction after orthotopic heart transplantation: the Vienna experience 1987-1993. Pacing Clin Electrophysiol 1994; 17: 2057-2063.
5. Melton IC, Gilligan DM, Wood MA, Ellenbogen KA. Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 1999; 22: 1510-1527.
6. Heinz G, Ohner T, Laufer G, Gossinger H, Gasic S, Laczkovics A. Demographic and perioperative factors associated with initial and prolonged sinus node dysfunction after orthotopic heart transplantation. The impact of ischemic time. Transplantation 1991; 51: 1217-1224.
7. Scott CD, Dark JH, McComb JM. Sinus node function after cardiac transplantation. J Am Coll Cardiol 1994; 24: 1334-1341.
8. Heinz G, Hirschl M, Buxbaum P, Laufer G, Gasic S, Laczkovics A. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long term implications. PACE 1992; 15: 731-737.
9. Heinz G, Kratochwill C, Koller-Strametz J. Benign prognosis of early sinus node dysfunction after orthotopic cardiac transplantation. PACE 1998; 21: 422-429.
10. Lower RR, Shumway NE. Studies on the orthotopic transplantation homotransplantation of the canine heart. Surg Forum 1960; 11: 18-19.
11. Wilson BD, Clarkson CE, Lippmann ML. Amiodarone causes decreased cell-mediated immune responses and inhibits the phospholipase C signaling pathway. Lung 1993; 171: 137-148.
12. Akoun GM, Cadranel JL, Blanchette G, Milleron BJ, Mayaud CM. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients. Chest 1991; 99: 1177-1182.
13. Akoun GM, Gauthier-Rahman S, Millerone BJ, Perrot JY, Maynaud CM. Amiodarone-induced hypersensitivity pneumonitis. Chest 1984; 85: 133-135.
14. Redmond JM, Zehr KJ, Gillinov MA et al. Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transplant 1993; 12: 133-138, discussion 138-139.
15. Belardinelli L, Mattos EC, Berne RM. Evidence of adenosine mediation of atrioventricular block in the ischemic myocardium. J Clin Invest 1981; 68: 195-205.
16. Ellenbogen KA, Thames MD, DiMarco JP. Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity, Circulation 1990; 81: 821-828.
17. Bertolet BD, Eagle DA, Conti JB, Mills RM, Belardinelli L, Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 1996; 28: 396-399.
18. Moriatsu T, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-2690.
19. Mackintosh AF, Carmichael DJ, Wren C, Cory-Pearce R, English TA. Sinus node function in first three weeks after cardiac transplantation. Br Heart J 1982; 48: 584-588.
20. Blanche C, Czer LS, Trento A et al. Bradyarrhythmias requiring pacemaker implantation after orthotopic heart transplantation: association with rejection. J Heart Lung Transplant 1992; 11: 446-452.
21. Julian DG, Camm AJ, Frangin G et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997; 349: 667-674.
22. Cairns JA, Connolly SJ, Roberts R, Gent M. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349: 675-682.
23. Nanas JN, Anastasiou-Nana MI, Margari ZJ, Karli J, Moulopoulos SD. Redistribution of amiodarone in heart transplant recipients treated with the drug before operation. J Heart Lung Transplant 1997; 16: 387-389.
24. Chelimsky-Fallick C, Middlekauff HR, Stevenson WG et al. Amiodarone therapy does not compromise subsequent heart transplantation. J Am Coll Cardiol 1992; 20: 1556-1561.
25. Macdonald P, Hackworthy R, Keogh A, Sivathasan C, Chang V, Spratt P. The effect of chronic amiodarone therapy before transplantation on early cardiac allograft function. J Heart Lung Transplant 1991; 10: 743-749.
26. Chin C, Feindel C, Cheng D. Duration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantation. J Cardiothorac Vasc Anesth 1999; 13: 562-566.
27. Miller LW, Young JB. Physiology of the transplanted heart. In: Primer on Transplantation. American Society of Transplant Physicians; 1998. pp 435-437.
28. Rabinowe SL, Larsen PR, Antman EM et al. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Am J Med 1986; 81: 53-57.
29. Nicolau DP, Uber WE, Crumbley AJ, 3rd, Strange C. Amiodarone-cyclosporine interaction in a heart transplant patient. J Heart Lung Transplant 1992; 11: 564-568.
30. Chitwood KK, Abdul-Haqq AJ, Heim-Duthoy KL. Cyclosporine-amiodarone interaction. Ann Pharmacother 1993; 27: 569-571.
31. Kobashigawa JA, Naftel DC, Bourge RC et al. and the Transplant Cardiologists Research Database Group. Pre-transplant risk factors for acute rejection after cardiac transplantation: a multiinstitutional study. J Heart Lung Transplant 1993; 12: 355-366.
32. Jarcho J, Naftel DC, Shroyer TW et al. and the Cardiac Transplant Research Database Group. Influence of HLA mismatch on rejection after cardiac transplantation: a multi-institutional study. J Heart Lung Transplant 1994; 13: 583-596.
33. Kubo SH, Naftel DC, Mills RC et al. Risk factors for late recurrent rejection after cardiac transplantation, a multi-institutional, multivariable analysis. J Heart Lung Transplant 1995; 14: 409-418.
34. Mills RM, Jr, Naftel DC, Kirklin JK et al. and the Cardiac Transplant Research Database Group. Cardiac transplant rejection with hemodynamic compromise: a multi-institutional study of risk factors and endomyocardial cellular infiltrate. J Heart Lung Transplant 1997; 16: 813-821.
35. Taylor DO. Immunosuppressive therapies after heart transplantation: best, better and beyond. Curr Opin Cardiol 2000; 15: 108-114.